๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2026-03-31

A Phase 2A Trial of DT402 for Autism Spectrum Disorder (NCT07303907)

An Open-label Study Evaluating DT402 in Adults With Autism Spectrum Disorder

๐ŸŸข Recruiting Phase2 ๐Ÿ’Š Investigational Drug / Biologic Sponsor: Definium Therapeutics US, Inc.

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

A Phase 2A Trial of DT402 Open-Label Study in Adults with Autism Spectrum Disorder

Who can join: Review the eligibility criteria below.

Location: Spectrum Neuroscience and Treatment Institute โ€” New York, New York

Age range: 18 Years to 65 Years

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (1 Sites)

  • Spectrum Neuroscience and Treatment Institute โ€” New York, New York

๐Ÿ“ž Contact the Study Coordinator

Phone: (332) 282-0479

Email: clinicaltrials@definiumtx.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—